Problem 23 - Biological Psychology

Question

What are some possible treatments for Parkinson's disease other than L-dopa?

Step-by-Step Solution

Answer

Treatments include Deep Brain Stimulation, MAO-B inhibitors, dopamine agonists, COMT inhibitors, and anticholinergics.

Step 1: Deep Brain Stimulation

Deep Brain Stimulation (DBS) is a surgical procedure used to treat Parkinson's disease. It involves implanting electrodes in specific brain areas which emit electrical impulses to regulate abnormal impulses. The procedure can help reduce tremors and other movement-related symptoms.

Step 2: MAO-B Inhibitors

Monoamine Oxidase B (MAO-B) inhibitors are another treatment option. These medications work by blocking the MAO-B enzyme, which breaks down dopamine in the brain, thereby enhancing and prolonging the effects of dopamine and reducing symptoms of Parkinson's disease.

Step 3: Dopamine Agonists

Dopamine agonists are drugs that mimic the action of dopamine in the brain. They can bind to dopamine receptors and stimulate them, offering a similar effect to that of naturally occurring dopamine, and are often used in the early stages of Parkinson's disease or in combination with other medications.

Step 4: Catechol-O-methyltransferase (COMT) Inhibitors

COMT inhibitors work by blocking the enzyme that breaks down dopamine, thus prolonging the effects of L-dopa in the body. These are often used in conjunction with L-dopa therapy to improve its efficacy.

Step 5: Anticholinergics

Anticholinergic drugs help reduce tremors by affecting the neurotransmitter acetylcholine, which can be out of balance in patients with Parkinson's disease. These medications are generally used to treat tremors and muscle stiffness.

Key Concepts

Deep Brain Stimulation

Deep Brain Stimulation (DBS) is a modern surgical technique used to manage Parkinson's disease. It entails placing electrodes in particular areas of the brain. These electrodes are connected to a small generator implanted in the chest. This generator sends electrical signals to the electrodes to help regulate electrical impulses in the brain, which can be abnormal in Parkinson’s disease.
DBS can significantly alleviate symptoms like tremors and rigidity, improving life quality for those with Parkinson's.
Although it is not a cure for the disease, it offers a valuable alternative when medications are not enough to control symptoms.

• DBS is generally considered for patients whose symptoms can't be managed by medication alone.
  
• The procedure is adjustable, meaning the frequency and intensity of the electrical impulses can be modified without further surgery.
  

However, DBS might not be suitable for everyone and carries risks, such as infection or complications related to the surgical procedure.

MAO-B Inhibitors

Monoamine Oxidase B (MAO-B) inhibitors are often prescribed for early-stage Parkinson’s disease to boost dopamine levels in the brain. They block the MAO-B enzyme, responsible for breaking down dopamine. By preventing this breakdown, MAO-B inhibitors effectively increase and prolong the action of dopamine.
This pathway helps mitigate symptoms like stiffness and slowness of movement.
Some common MAO-B inhibitors are selegiline and rasagiline.

• Useful in early stages and for mild symptoms.
  
• Often combined with other medications to improve overall treatment efficacy.
  

Patients using MAO-B inhibitors must watch for interactions with certain foods and medications, which can result in adverse effects.

Dopamine Agonists

Dopamine agonists play an essential role in treating Parkinson’s disease and work by imitating the effects of dopamine. They bind to dopamine receptors, stimulating them similarly to natural dopamine.
These drugs help manage symptoms, especially in the early phases of the disease or in conjunction with other treatments like L-dopa.
Dopamine agonists include pramipexole and ropinirole.

• Particularly beneficial for younger patients to delay the use of L-dopa.
  
• Can be administered orally or via skin patches for extended-release formulations.
  

It's essential for patients to start on a low dose and gradually increase, as side effects such as dizziness or sleepiness can occur.

COMT Inhibitors

Catechol-O-methyltransferase (COMT) inhibitors are often used in Parkinson’s treatment plans in combination with L-dopa. These drugs prevent COMT from breaking down dopamine in the brain, which allows L-dopa to have a more prolonged effect.
This can lead to better symptom management and fewer fluctuations as medication levels stabilize.
COMT inhibitors commonly used include entacapone and tolcapone.

• They enhance the duration and effectiveness of L-dopa treatment.
  
• Can help manage 'wearing-off' symptoms experienced between L-dopa doses.
  

Regular monitoring of liver function is necessary for patients using some COMT inhibitors due to potential side effects.

Anticholinergics

Anticholinergic medications are a traditional option in treating Parkinson's disease, particularly effective for tremor control. These drugs work by targeting the neurotransmitter acetylcholine, rebalancing its levels in the brain.
This can help reduce tremors and muscle stiffness commonly seen in Parkinson's patients.
Examples of anticholinergic medications include benztropine and trihexyphenidyl.

• Primarily used to control tremor rather than broader Parkinson's symptoms.
  
• Not suitable for older patients due to risk of side effects like confusion or memory problems.
  

As with any medication, it's crucial to balance the benefits with possible side effects, tailoring treatment to each individual's needs.